BLADE AIR MOBILITY INC C/WTS 07/05/2026 (TO PUR COM) | 10-Q: FY2025 Q1 Revenue: USD 54.31 M

Revenue: As of FY2025 Q1, the actual value is USD 54.31 M.

EPS: As of FY2025 Q1, the actual value is USD -0.04.

Passenger Segment

• Revenue: $18.4 million for the three months ended March 31, 2025, an increase of 18.5% from $15.5 million in 2024.
• Adjusted EBITDA: Improved by $2.7 million from - $2.7 million in 2024 to $0.1 million in 2025, driven by higher revenue and lower cost of revenue as a percentage of revenue in Europe and Jet charter.

Medical Segment

• Revenue: $35.9 million for the three months ended March 31, 2025, a decrease of 0.2% from $36.0 million in 2024.
• Adjusted EBITDA: Decreased by $0.3 million, or 7.1%, from $4.4 million in 2024 to $4.1 million in 2025, largely due to lower utilization of the owned fleet.

Consolidated Financial Metrics

• Net Loss: Improved by $0.7 million from - $4.2 million in 2024 to - $3.5 million in 2025.
• Adjusted EBITDA: Improved by $2.3 million from - $3.5 million in 2024 to - $1.2 million in 2025.
• Gross Profit: Increased by $2.2 million from $5.9 million in 2024 to $8.1 million in 2025.
• Flight Profit: Increased by $1.8 million, or 18.1%, from $10.1 million in 2024 to $12.0 million in 2025.

Future Outlook and Strategy

• Core Business Focus: Blade Air Mobility, Inc. plans to leverage its asset-light model and proprietary technologies to transition to Electric Vertical Aircraft (EVA), aiming for lower cost, quiet, and emission-free air mobility.
• Non-Core Business: The company is focusing on expanding its MediMobility Organ Transport services and enhancing its technology-enabled solutions for organ transport logistics.